Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.

Lin TY, Chang JT, Wang HM, Chan SH, Chiu CC, Lin CY, Fan KH, Liao CT, Chen IH, Liu TZ, Li HF, Cheng AJ.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):246-56. doi: 10.1016/j.ijrobp.2010.03.002.

PMID:
20615631
2.

Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15.

Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Wang TH, Lee LY, Cheng AJ.

Mol Cancer Ther. 2007 Aug;6(8):2271-9. Epub 2007 Aug 1.

PMID:
17671084
3.

Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.

Aloy MT, Hadchity E, Bionda C, Diaz-Latoud C, Claude L, Rousson R, Arrigo AP, Rodriguez-Lafrasse C.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):543-53. Epub 2007 Nov 5.

PMID:
17980509
4.

Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer.

Chiu CC, Lin CY, Lee LY, Chen YJ, Lu YC, Wang HM, Liao CT, Chang JT, Cheng AJ.

Clin Cancer Res. 2011 Jul 15;17(14):4629-41. doi: 10.1158/1078-0432.CCR-10-2107. Epub 2011 Jun 3.

PMID:
21642380
5.

Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.

Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M.

Int J Oncol. 2006 Mar;28(3):705-13.

PMID:
16465376
6.

Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production.

Kim JS, Chang JW, Yun HS, Yang KM, Hong EH, Kim DH, Um HD, Lee KH, Lee SJ, Hwang SG.

Proteomics. 2010 Jul;10(14):2589-604. doi: 10.1002/pmic.200900523.

PMID:
20461716
7.

Differential expression of proteins in radioresistant and radiosensitive human squamous carcinoma cells.

Ramsamooj P, Kasid U, Dritschilo A.

J Natl Cancer Inst. 1992 Apr 15;84(8):622-8.

PMID:
1556773
8.

Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.

Kong Z, Raghavan P, Xie D, Boike T, Burma S, Chen D, Chakraborty A, Hsieh JT, Saha D.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1210-8. doi: 10.1016/j.ijrobp.2010.06.019.

PMID:
20970033
9.

Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity.

Lee YS, Chang HW, Jeong JE, Lee SW, Kim SY.

Acta Otolaryngol. 2008 Jan;128(1):86-92.

PMID:
17917836
10.

DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.

Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ.

Oncogene. 2007 Jan 18;26(3):467-76. Epub 2006 Jul 31.

PMID:
16878157
11.

Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention.

Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JT, Liao CT, Wang HM, Yen TC, Shen CR, Liao SK, Cheng AJ.

Mol Cancer Ther. 2008 Sep;7(9):2788-97. doi: 10.1158/1535-7163.MCT-08-0172.

PMID:
18790759
12.

Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.

Sørensen BS, Horsman MR, Vorum H, Honoré B, Overgaard J, Alsner J.

Radiother Oncol. 2009 Sep;92(3):443-9. doi: 10.1016/j.radonc.2009.05.019. Epub 2009 Jun 21.

PMID:
19541378
13.

Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.

Chiu CC, Lee LY, Li YC, Chen YJ, Lu YC, Li YL, Wang HM, Chang JT, Cheng AJ.

Cancer Gene Ther. 2013 Nov;20(11):606-15. doi: 10.1038/cgt.2013.64. Epub 2013 Nov 8.

PMID:
24201869
14.

Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation.

Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, Hagiwara A, Mitsufuji S, Okazaki Y, Hayashizaki Y, Yamagishi H.

Br J Cancer. 2004 Oct 18;91(8):1543-50.

PMID:
15365572
15.

Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.

Ito E, Yue S, Moriyama EH, Hui AB, Kim I, Shi W, Alajez NM, Bhogal N, Li G, Datti A, Schimmer AD, Wilson BC, Liu PP, Durocher D, Neel BG, O'Sullivan B, Cummings B, Bristow R, Wrana J, Liu FF.

Sci Transl Med. 2011 Jan 26;3(67):67ra7. doi: 10.1126/scitranslmed.3001922.

PMID:
21270338
16.
17.

Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.

Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, Cai R, Jin Y, Dong B, Xu Y, Wang Y.

J Natl Cancer Inst. 2010 Jul 21;102(14):1052-68. doi: 10.1093/jnci/djq217. Epub 2010 Jun 16.

PMID:
20554944
18.

Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases.

Carta F, Demuro PP, Zanini C, Santona A, Castiglia D, D'Atri S, Ascierto PA, Napolitano M, Cossu A, Tadolini B, Turrini F, Manca A, Sini MC, Palmieri G, Rozzo AC; Italian Melanoma Intergroup..

Melanoma Res. 2005 Aug;15(4):235-44.

PMID:
16034300
19.

Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.

Yang W, Sun T, Cao J, Liu F.

Int J Radiat Biol. 2010 Jun;86(6):445-57. doi: 10.3109/09553001003668006.

PMID:
20470195
20.

Supplemental Content

Support Center